Targeting Pain Without Addiction Risk
AI Gene Therapy Offers Non-Addictive Pain Relief
University of Pennsylvania researchers use AI mapping to target brain circuits for morphine-level pain management.
A digital rendering of a human brain with glowing neural circuits being mapped by AI for medical treatment.
Photo: Avantgarde News
Scientists at the University of Pennsylvania developed a gene therapy to treat chronic pain without the risk of addiction [1][2]. The team used artificial intelligence to map specific pain-processing circuits in the brain [1][3]. This allows the treatment to target only the necessary areas for relief [2]. The new therapy provides pain relief comparable to morphine [1]. However, it avoids the side effects and dependency issues associated with traditional opioids [2][3]. Researchers believe this "switch" mechanism could revolutionize how doctors manage severe pain in clinical settings [1][2].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The provided source list includes three links but only two independent organizational entities (ScienceDaily and University of Pennsylvania), failing the requirement for three independent domains.
Sources
- 1.↗
ScienceDaily
AI-Mapped Gene Therapy Offers Non-Addictive Pain Relief
University of Pennsylvania scientists have developed a new gene therapy that targets specific pain-processing circuits in the brain, identified using AI mapping, to provide morphine-level relief without the risk of addiction.
Back to reference
Related stories
View all
Topics
About the author
Avantgarde News Desk covers targeting pain without addiction risk and editorial analysis for Avantgarde News.